srdan verstovsek, md, on predicting resistance to hydroxyurea therapy in polycythemia vera
Published 1 year ago • 135 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
1:57
dr. verstovsek on jak inhibition in polycythemia vera
-
20:15
hydroxyurea intolerance/resistance in polycythemia vera
-
1:49
dr. verstovsek on benefit of ruxolitinib in polycythemia vera
-
1:56
rationale for verify: rusfertide added to ongoing therapy in patients with polycythemia vera
-
21:43
hydroxyurea intolerance/resistance in polycythemia vera
-
32:29
current developments in polycythemia vera treatment: is it curable?
-
10:57
how to treat polycythemia vera, what are the causes and symptoms
-
32:34
current management of polycythemia vera - richard t. silver, md
-
5:50
machine-learning to predict hydroxyurea failure & thromboembolic events in polycythemia vera
-
0:54
polycythemia vera (pv): is resistance to hydroxyurea prognostic for adverse outcomes?
-
16:19
latest on current treatments for myelofibrosis, polycythemia vera, essential thrombocythemia
-
5:43
moving beyond hydroxyurea for polycythemia vera
-
23:44
2nd line therapy for patients diagnosed with polycythemia vera (pv)
-
2:08
expert talks side effects of pv treatment
-
0:57
moving beyond hydroxyurea in polycythemia vera
-
2:05
srdan verstovsek, md, phd: the risk of thrombosis in pv
-
1:19
what are the treatment options for soft tissue sarcoma?
-
38:20
new mpn treatments and drugs - srdan verstovsek, md, phd
-
1:45
evaluating cpi-0610 as treatment of patients with myelofibrosis
-
17:31
how do you treat pv patients that fail hydroxyurea (hu)?
-
1:40
challenges and options for patients with hydroxyurea-resistant pv
-
0:52
reveal study: long-term analysis of ruxolitinib in patients with polycythemia vera after hydroxyurea